Alexander Behnaz, MD
Physical Medicine & Rehabilitation · Pittsburgh, PANPI 1902398449
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $14,455 of the $17,595 with a category attached, or 82.2%. 38 manufacturers reported payments, led by Medtronic at 44.3% of the total. Reporting peaked in 2024 at $8,260 and has fallen 50.2% since, to $4,109 in 2025. Among physical medicine & rehabilitation clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 310 payments — averaging $56.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Abbott$3K
- Curonix LLC$2K
- MML US, Inc.$1K
- Boston Scientific$889
- Vertos Medical, Inc.$694
- plus $2K from 32 others
What the payments were for
- Travel & lodging$3,12118%
- Food & beverage$14,45582%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 130 | $7,792 |
| Abbott | 56 | $3,068 |
| Curonix LLC | 20 | $1,576 |
| MML US, Inc. | 9 | $1,159 |
| Boston Scientific | 15 | $889 |
| Vertos Medical, Inc. | 7 | $694 |
| AbbVie(2 entities) | 16 | $402 |
| Neurocrine Biosciences, Inc. | 3 | $190 |
| Axogen | 2 | $149 |
| Pacira Pharmaceuticals Incorporated | 2 | $145 |
| Axsome Therapeutics, Inc. | 6 | $142 |
| Amneal Pharmaceuticals LLC | 5 | $112 |
| Lundbeck LLC | 4 | $112 |
| EMD Serono, Inc. | 1 | $104 |
| Biogen | 4 | $100 |
| Relievant Medsystems, Inc. | 1 | $100 |
| Impel Pharmaceuticals Inc. | 1 | $90 |
| Lilly USA, LLC | 4 | $88 |
| Nevro Corp. | 1 | $84 |
| Bioventus LLC | 1 | $83 |
| SPR Therapeutics, Inc | 1 | $81 |
| Tersera Therapeutics LLC | 2 | $66 |
| Eisai Inc. | 2 | $40 |
| Johnson & Johnson(2 entities) | 2 | $35 |
| CSL Behring | 1 | $29 |
| Pfizer | 1 | $27 |
| Neurelis, Inc. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Electronic Waveform Lab, Inc. | 2 | $22 |
| Painteq LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| UCB, Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Convatec Inc. | 1 | $15 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$2,713
- SYNCHROMEDII$1,921
- PROCLAIM$1,378
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$1,223
- ReActiv8$1,072
- ETERNA$711
- mild Device Kit$619
- INCEPTIV$405
- Intracept$400
- Infinion 16$313
- WaveWriter Alpha Prime 16$131
- VANTA ADAPTIVESTIM$130
- EXPAREL$124
- INGREZZA$119
- Mavenclad$104
How this compares
$17,595 in reported general payments places this provider in the 95th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.
See all physical medicine & rehabilitation providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 186 | $2,464 |
| Baclofen | 62 | $2,117 |
| Lidocaine | 13 | $1,938 |
| Naloxone Hcl | 31 | $1,904 |
| Pregabalin | 60 | $1,826 |
| Diclofenac Sodium | 49 | $1,243 |
| Methocarbamol | 109 | $797 |
| Buprenorphine | 12 | $793 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 55 | $664 |
| Celecoxib | 11 | $609 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $514 |
| Naproxen | 32 | $480 |
| Tizanidine Hcl | 21 | $423 |
| Duloxetine Hcl | 28 | $393 |
| Tramadol Hcl | 46 | $281 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Pittsburgh
- Michael MuninPittsburgh$43K
- Shelana Gibbs-McelvyPittsburgh$39K
- Colton HickmanPittsburgh$9K
- Kentaro OnishiPittsburgh$6K
- Karl LiebePittsburgh$5K
- John LeePittsburgh$4K
- Thomas FranzPittsburgh$4K
- Jeffery RoweKing Of Prussia$1.9M
- Michael SaulinoElkins Park$425K
- Huaguang QuChalfont$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.